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Existing models of Huntington’s disease posit that deficits in BDNF delivery to the striatum contribute to
atrophy andmotor impairment. In this issue ofNeuron, Plotkin et al. (2014) show that BDNF delivery is normal
but downstream signaling via TrkB and p75 is impaired, leading to corticostriatal synaptic dysfunction.Huntington’s disease (HD) is a fatal neuro-
degenerative disorder caused by a CAG
repeat expansion in the gene encoding
the huntingtin protein. This mutation re-
sults in progressive neurodegeneration
that is most striking in the striatum. HD
is characterized by motor incoordination
and involuntary choreic or dance-like
movements; the latter arise primarily as
a result of the inability of aberrant
cortical-striatal circuits to suppress un-
wanted motor output. Notably, prior to
extensive cell death, subtle physiological
changes are known to occur within the
striatum (Raymond et al., 2011). Thus,
there is hope for delaying or preventing
the symptoms of HD by elucidating these
early alterations and their underlying
mechanisms. As the genetic cause of
HD is known (The Huntington’s Disease
Collaborative Research Group, 1993), a
variety of mouse lines have been gener-
ated that model the genetics, neuropa-
thology, and motor impairments seen in
human HD, and these models have
proven invaluable to the understanding
of this disease (Pouladi et al., 2013).
One of the early impairments is thought
to be a reduction in the amount of brain-
derived neurotrophic factor (BDNF) that
is delivered to the striatum. The striatum
itself expresses little to no BDNF and
rather relies on anterograde transport
and release of BDNF from cortical affer-
ents for trophic support (Altar et al.,
1997). As a result of the HD mutation, it
has been shown previously that BDNF
production in the cortex is reduced, as is
its delivery to the striatum (Gauthier
et al., 2004; Zuccato et al., 2001), and
this is often cited as a plausible reason6 Neuron 83, July 2, 2014 ª2014 Elsevier Incfor the striatum’s vulnerability in HD. In
this issue of Neuron, Plotkin et al. (2014)
use multiple primers and reference genes
to convincingly show that BDNF produc-
tion and delivery to the striatum in HD
may not be as impaired as previously
thought. They show, in both bacterial arti-
ficial chromosome (BAC) and heterozy-
gous knockin (zQ175) mouse models of
HD, that BDNF production by the cortex
is normal, as is the activity-dependent
activation of TrkB receptors in the stria-
tum. Although the precise reasons for
the inconsistencies among different
studies and HD models remain unclear,
Plotkin et al. (2014) suggest that the
discrepancy is due in large part to the
fact that previous studies compared
BDNF expression to single reference
genes that showed variable expression.
It should be noted that Plotkin et al.
(2014) observed some evidence of
decreased cortical BDNF expression
when they examined a more rapidly pro-
gressing homozygous knockin model of
HD, and there is also evidence of reduced
BDNF in postmortem tissue from human
HD patients (Zuccato et al., 2008). Thus,
although reduced BDNF expression and/
or delivery to the striatum may contribute
to HD pathology, the data presented in
Plotkin et al. (2014) now, for the first
time, question whether this deficit is a
major pathogenic mechanism.
The BAC and heterozygous knockin HD
models used in this study both exhibit
progressive motor and cognitive symp-
toms, as well as HD-relevant neuropa-
thology (Gray et al., 2008; Menalled
et al., 2012). So, what role, if any, does
BDNF play in these particular HDmodels?.Instead of a delivery problem, the current
study indicates that it is the processing
of the BDNF signal in the striatum that
appears to be aberrant in HD. The
majority of the striatum is comprised of
medium-sized spiny projection neurons
(SPNs), which make up the well-estab-
lished direct (dSPNs) and indirect (iSPNs)
pathways of the basal ganglia responsible
for movement initiation and suppression,
respectively (Gerfen and Surmeier,
2011). In HD, the D2 dopamine receptor-
expressing iSPNs are known to degen-
erate first, giving rise to involuntary,
choreic movements. Later in disease pro-
gression, the D1 receptor-expressing
dSPNs are affected, resulting in a shift
toward an akinetic and rigid stage. Here,
Plotkin et al. (2014) use a cleverly de-
signed set of experiments to assess
BDNF signaling in individual SPNs. They
describe a form of synaptic plasticity
that can be induced in single, phenotypi-
cally defined striatal neurons, is detected
at the level of dendritic spines, and relies
upon BDNF actions on postsynaptic
TrkB receptors. As BDNF is delivered to
the striatum via cortical and not thalamic
afferents, they use channelrhodopsin to
show that this form of plasticity is
restricted to corticostriatal synapses.
Strikingly, BDNF-dependent potentiation
is progressively impaired in the HD stria-
tum but only at cortical synapses onto
iSPNs and not dSPNs, thereby providing
a putative mechanism underlying the mo-
tor phenotype that plagues early symp-
tomatic HD. The plasticity deficit is due
to enhanced signaling downstream of
the p75 neurotrophin receptor, which,
along with the TrkB receptor, also binds
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Figure 1. Mechanisms of iSPN Plasticity and Its Impairment in Huntington’s Disease
Diagram depicting the signaling pathways required to induce potentiation at corticostriatal synapses in
iSPN (left) and the aberrant signaling observed in the BACHD mouse (right).
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Specifically, the expression of phospha-
tase and tensin homolog (PTEN) down-
stream of p75 receptor activation is
enhanced exclusively in HD iSPNs.
Knockdown or inhibition of p75 or its
downstream targets restores plasticity in
these cells.
Aside from its relevance to HD, this
study comprehensively describes a
novel form of synaptic potentiation in the
striatum. By examining potentitation at
the level of individual neurons, Plotkin
et al. (2014) have revealed strict induction
criteria that are required to observe
potentiation at glutamatergic synapses
in the striatum. First, potentiation is
dependent on convergent signaling
between TrkB, NMDA, and G protein-
coupled receptors; antagonism of any
one component is sufficient to inhibit
plasticity. Second, potentiation is res-
tricted to only corticostriatal synapses
and does not appear to occur at thala-
mostriatal synapses. Third, iSPNs and
dSPNs differ in the G protein-coupled
receptor that is involved in plasticity in-
duction. By describing this form of plas-
ticity in-depth, Plotkin et al. (2014) have
provided the community with a valuable
tool to assess potentiation at defined
synapses onto phenotypically identified
striatal neurons that will be useful for
assessment of corticostriatal plasticity in
other movement disorders.
While unable to replicate the previous
general understanding of a BDNF deficit
in HD, Plotkin et al. (2014) clearly show a
plasticity deficit in the HD striatum that isspecific to iSPNs and is a result of altered
signaling downstream of a BDNF recep-
tor. These data provide valuable clues
toward developing better treatment for
involuntary movements in early symptom-
atic HD. Given the known deleterious
signaling mediated by the p75 receptor
(reviewed in Fujii and Kunugi, 2009),
targeting this pathway may also offer
neuroprotection. On the other hand, the
previous literature highlighting a BDNF
production and delivery deficit is simply
too large to ignore. Taking all findings
into account, there remains some uncer-
tainty as to how to proceedwith therapeu-
tic development in HD. For example, if
BDNF production and delivery deficits
significantly contribute to HD pathogen-
esis as previously thought, then perhaps
the concentration of BDNF released in
the HD striatum by synaptic activity would
be too low to significantly coactivate the
relatively low-affinity p75 receptor. It
should be noted that the BACHD model
shows reduced synaptic activity at the
age at which the plasticity deficit is
observed (Gray et al., 2008). Thus, it
remains unclear whether agonizing TrkB
receptors, antagonizing p75 receptors,
or a combination of both would produce
the most favorable effect. Indeed, it was
recently shown that long-term systemic
treatment with LM22A-4, a specific TrkB
agonist without actions at the p75 recep-
tor, ameliorated the spine loss and motor
symptoms in HD mice (Simmons et al.,
2013). It is possible that simultaneous
inhibition of the p75 receptor could
augment these beneficial effects. In anyNecase, the results of Plotkin et al. (2014)
caution strategies aiming to simply in-
crease general BDNF levels and provide
convincing evidence to support p75
antagonism in the treatment of early
symptomatic HD.
As with all good studies, many ques-
tions are answered while others are
raised. Since the form of corticostriatal
synaptic plasticity described here is
novel, its relevance to movement regula-
tion, and therefore its importance to HD
pathology, remains unknown. It would
be of great interest to determine whether
inhibitors of the p75 receptor or its down-
stream signaling—treatments that restore
iSPN plasticity—can rescue motor defi-
cits observed in the BACHD model (Gray
et al., 2008). The results reported here
also raise questions as to the mecha-
nism(s) underlying the mutant huntingtin-
associated increase in PTEN expression
and function. Moreover, the question of
why the BDNF/TrkBR signaling network
in the BACHD mice is attenuated selec-
tively in striatal iSPNs while it is elevated
in dSPNs remains to be addressed. On a
separate note, accumulating evidence
suggests that NMDA receptors located
outside of the synapse (extrasynaptic
NMDARs) can impair synaptic potentia-
tion in the hippocampus (reviewed in
Parsons and Raymond, 2014); although
extrasynaptic NMDAR activation is
known to be enhanced in HD striatal
neurons (Milnerwood et al., 2010), the
striatal synaptic potentiation here was
restored after p75 signaling inhibition.
The role of extrasynaptic NMDARs, if
any, in this form of corticostriatal plasticity
remains to be determined.
The exciting findings presented in Plot-
kin et al. (2014) are sure to spark interest,
and perhaps some controversy, as to the
precise role of BDNF in HD pathogenesis.
Further investigation of a variety of HD
mouse models as well as human brain
tissue at different HD stages, to determine
the contribution of a BDNF production
and delivery deficit (or lack thereof), is
crucial for guiding therapeutic strategies.
Nonetheless, the newly described form
of striatal plasticity should prove valuable
for future studies into the mechanisms
underlying a variety of movement disor-
ders. Last, but certainly not least, the
highlighted contribution of the p75 neuro-
trophin receptor and its downstreamuron 83, July 2, 2014 ª2014 Elsevier Inc. 7
Neuron
Previewssignaling in HD striatum parallels studies
that demonstrate a role for this receptor
in other neuropsychiatric disorders (Fujii
and Kunugi, 2009) and provides a novel,
promising set of therapeutic targets for
the treatment of HD.
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Learning can be facilitated by previous knowledge when it is organized into relational representations
forming schemas. In this issue of Neuron, McKenzie et al. (2014) demonstrate that the hippocampus rapidly
forms interrelated, hierarchical memory representations to support schema-based learning.Oneof the timelyquestionsofhippocampal
research is to understand how learning in-
fluences hippocampal neuronal represen-
tations. New information may be incorpo-
rated into already existing representations
or entirely new representations could be
formed to prevent interference with previ-
ously formed memories. Schema-based
learning would require the formation of
interrelated memory representation into
which new information could be rapidly
assimilated (Tse et al., 2011). In this issue
of Neuron, McKenzie et al. (2014) show
that hippocampal cognitive maps can
form such representations: different repre-
sentations can be hierarchically organized,
incorporating both spatial and task-related
mnemonic information.
Using two different environments linked
by a tunnel (Figure 1A), McKenzie et al.
(2014) probed how hippocampal firingpatterns reflect learned associations be-
tween objects, the presence of a reward,
and environment (or context). Rats had
to learn that in the first environment, one
of two objects (flower pots, scented with
different odors and containing different
digging media) was rewarded, even
when the position of the objects was
swapped around. In the second environ-
ment, the rules were reversed, so that
the other object was rewarded. Once
learned, animals were able to associate
the presence of a reward with new objects
over far fewer trials, consistent with a
schema-based learning. How does the
hippocampal network encode different
features of this task? And how is new in-
formation incorporated into previously
formed representations?
To answer these questions, McKenzie
et al. (2014) recorded from CA3 and CA1pyramidal cells as rats performed this
task, with two sets of objects (AB or
CD), in randomly interleaved trials,
focusing on the firing patterns around
the point at which the animal sampled
the object (Figure 1A). The majority of
recorded cells showed differential firing
responses, depending on the location or
identity of the object sampled. In addition
to position, many cells also encoded
information about the object, including
the object’s identity, the set (AB or CD)
to which it belonged, and whether the
object was baited or not (valence). In this
way, hippocampal population activity, or
‘‘cell assemblies’’ of such neurones, can
collectively represent the spatial and
nonspatial features of the task.
If cell-assembly coding of memory
traces reflect distinct and separate repre-
sentations, one might expect the
